Pfizer is recalling millions of prescription migraine drugs after the U.S. Consumer Product Safety Commission found that the drugs do not meet the proper packaging requirements under federal law. These packaging issues have led to child safety concerns, including accidental overdose. The drugs were distributed between December 2021 and March 2023, and they are just now being dealt with. Pfizer migraine...